Zitha Redempta Isingizwe

6PUBLICATIONS
11CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
Identification and Experimental Validation of Triosephosphate Isomerase 1 as a Functional Biomarker of SHetA2 Sensitivity in Ovarian Cancer.

Laura F Mortan, Zitha Redempta Isingizwe, Doris Mangiaracina Benbrook

|Mar 13, 2025
Cognitive Performance in Relation to Systemic and Brain Iron at Perimenopause.

Amy L Barnett, Michael J Wenger, Pamela Miles

|Nov 26, 2024
Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer.

Justin Garland, Showket Hussain, Rajani Rai

|Nov 09, 2024
Elevated Platelet Aggregation in Patients with Ovarian Cancer: More than Just Increased Platelet Count.

Zitha Redempta Isingizwe, Brooke A Meelheim, Doris Mangiaracina Benbrook

|Oct 26, 2024
Implications of GPIIB-IIIA Integrin and Liver X Receptor in Platelet-Induced Compression of Ovarian Cancer Multi-Cellular Spheroids.

Zitha Redempta Isingizwe, Virginie Sjoelund, Doris Mangiaracina Benbrook

|Nov 27, 2021
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets.

Rajani Rai, Amy L Kennedy, Zitha Redempta Isingizwe

Pageof 1

Frequent Collaborators

6 joint publications

Doris Mangiaracina Benbrook

2 joint publications

Rajani Rai

1 joint publications

Pouya Javadian

1 joint publications

Virginie Sjoelund